China Oncology Drugs Industry Market Analysis & Forecast 2018-2023

June 2018 | 135 pages | ID: CA3850B0689EN
S&P Consulting

Abstracts

In the China Oncology Drugs Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

The Major players reported in the market include:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.

China Oncology Drugs Market: Product Segment Analysis
Blood Cancer
Breast Cancer
Others

China Oncology Drugs Market: Application Segment Analysis
Chemotherapy
Targeted Therapy
Others

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

China Oncology Drugs Industry Market Analysis & Forecast 2018-2023

CHAPTER 1 ONCOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Drugs
1.2 Oncology Drugs Market Segmentation by Type
  1.2.1 China Production Market Share of Oncology Drugs by Blood Cancern 2017
  1.2.1 Blood Cancer
  1.2.2 Breast Cancer
  1.2.3 Others
1.3 Oncology Drugs Market Segmentation by Application
  1.3.1 Oncology Drugs Consumption Market Share by Application in 2017
  1.3.2 Chemotherapy
  1.3.3 Targeted Therapy
  1.3.4 Others
1.4 China Market Size Sales (Value) and Revenue (Volume) of Oncology Drugs (2013-2023)

CHAPTER 2 CHINA ECONOMIC IMPACT ON ONCOLOGY DRUGS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Oncology Drugs Industry

CHAPTER 3 CHINA ONCOLOGY DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 China Oncology Drugs Production and Share by Manufacturers (2016 and 2017)
3.2 China Oncology Drugs Revenue and Share by Manufacturers (2016 and 2017)
3.3 China Oncology Drugs Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Oncology Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Drugs Market Competitive Situation and Trends
  3.5.1 Oncology Drugs Market Concentration Rate
  3.5.2 Oncology Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA ONCOLOGY DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2013-2018)

4.1 China Oncology Drugs Capacity, Production and Growth (2013-2018)
4.2 China Oncology Drugs Revenue and Growth (2013-2018)
4.3 China Oncology Drugs Production, Consumption, Export and Import (2013-2018)

CHAPTER 5 CHINA ONCOLOGY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Oncology Drugs Production and Market Share by Type (2013-2018)
5.2 China Oncology Drugs Revenue and Market Share by Type (2013-2018)
5.3 China Oncology Drugs Price by Type (2013-2018)
5.4 China Oncology Drugs Production Growth by Type (2013-2018)

CHAPTER 6 CHINA ONCOLOGY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Oncology Drugs Consumption and Market Share by Application (2013-2018)
6.2 China Oncology Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA ONCOLOGY DRUGS MANUFACTURERS ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Business Overview
7.2 Novartis
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Business Overview
7.5 Johnson & Johnson
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.5.4 Business Overview
7.6 GlaxoSmithKline
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Business Overview
7.7 Eli lilly & Co
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Business Overview
7.8 Pfizer
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Business Overview
7.9 Merck & Co.
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Business Overview

CHAPTER 8 ONCOLOGY DRUGS MANUFACTURING COST ANALYSIS

8.1 Oncology Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology Drugs

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Oncology Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA ONCOLOGY DRUGS MARKET FORECAST (2018-2023)

12.1 China Oncology Drugs Production, Revenue Forecast (2018-2023)
12.2 China Oncology Drugs Production, Consumption Forecast by Regions (2018-2023)
12.3 China Oncology Drugs Production Forecast by Type (2018-2023)
12.4 China Oncology Drugs Consumption Forecast by Application (2018-2023)
12.5 Oncology Drugs Price Forecast (2018-2023)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Drugs
Figure China Production Market Share of Oncology Drugs by Blood Cancern 2017
Table Oncology Drugs Consumption Market Share by Application in 2017
Figure China Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table China Oncology Drugs Capacity of Key Manufacturers (2016 and 2017)
Table China Oncology Drugs Capacity Market Share of Key Manufacturers (2016 and 2017)
Figure China Oncology Drugs Capacity of Key Manufacturers in 2016
Figure China Oncology Drugs Capacity of Key Manufacturers in 2017
Table China Oncology Drugs Production of Key Manufacturers (2016 and 2017)
Table China Oncology Drugs Production Share by Manufacturers (2016 and 2017)
Figure 2015 Oncology Drugs Production Share by Manufacturers
Figure 2016 Oncology Drugs Production Share by Manufacturers
Table China Oncology Drugs Revenue (Million USD) by Manufacturers (2016 and 2017)
Table China Oncology Drugs Revenue Share by Manufacturers (2016 and 2017)
Table 2015 China Oncology Drugs Revenue Share by Manufacturers
Table 2016 China Oncology Drugs Revenue Share by Manufacturers
Table China Market Oncology Drugs Average Price of Key Manufacturers (2016 and 2017)
Figure China Market Oncology Drugs Average Price of Key Manufacturers in 2016
Table Manufacturers Oncology Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Drugs Product Type
Figure Oncology Drugs Market Share of Top 3 Manufacturers
Figure Oncology Drugs Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
Figure Church & Dwight Oncology Drugs Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Roche Oncology Drugs Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Novartis Oncology Drugs Market Share (2013-2018)
Table Celgene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgene Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Celgene Oncology Drugs Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Amgen Oncology Drugs Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Johnson & Johnson Oncology Drugs Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table GlaxoSmithKline Oncology Drugs Market Share (2013-2018)
Table Eli lilly & Co Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli lilly & Co Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Eli lilly & Co Oncology Drugs Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer Oncology Drugs Market Share (2013-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck & Co. Oncology Drugs Production, Revenue, Price and Gross Margin (2013-2018)
Table Merck & Co. Oncology Drugs Market Share (2013-2018)
Figure Production Revenue Share of Oncology Drugs by Type (2013-2018)
Figure 2015 Revenue Market Share of Oncology Drugs by Type
Table China Oncology Drugs Price by Type (2013-2018)
Figure China Oncology Drugs Production Growth by Type (2013-2018)
Table China Oncology Drugs Consumption by Application (2013-2018)
Table China Oncology Drugs Consumption Market Share by Application (2013-2018)
Figure China Oncology Drugs Consumption Market Share by Application in 2016
Table China Oncology Drugs Consumption Growth Rate by Application (2013-2018)
Figure China Oncology Drugs Consumption Growth Rate by Application (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure China Oncology Drugs Capacity, Production and Growth Rate Forecast (2018-2023)
Figure China Oncology Drugs Revenue and Growth Rate Forecast (2018-2023)
Table China Oncology Drugs Production, Import, Export and Consumption Forecast (2018-2023)
Table China Oncology Drugs Production Forecast by Type (2018-2023)
Table China Oncology Drugs Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Roche Novartis Celgene Amgen Johnson & Johnson GlaxoSmithKline Eli lilly & Co Pfizer Merck & Co.